{"disease":{"id":"pulmonary-hypertension-primary","name":"pulmonary hypertension primary"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03626688","title":"A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":687,"lead_sponsor_name":"United Therapeutics","has_results":false},{"nct_id":"NCT03388476","title":"Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":500,"lead_sponsor_name":"University of Giessen","has_results":false},{"nct_id":"NCT04472533","title":"Serum Bio-markers in Pulmonary Hypertension","phase":"","overall_status":"COMPLETED","enrollment_count":377,"lead_sponsor_name":"Papworth Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT04808596","title":"Pulmonary Hypertension Biorepository and Registry","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University of Kansas Medical Center","has_results":false},{"nct_id":"NCT02229994","title":"Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03528902","title":"Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":true},{"nct_id":"NCT03344159","title":"Spironolactone Therapy in Chronic Stable Right HF Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Ottawa Heart Institute Research Corporation","has_results":false},{"nct_id":"NCT04084678","title":"A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"United Therapeutics","has_results":false},{"nct_id":"NCT04908397","title":"Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":true}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}